Clearstead Advisors, LLC Mimedx Group, Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 283 shares of MDXG stock, worth $2,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
283
Previous 339
16.52%
Holding current value
$2,088
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MDXG
# of Institutions
261Shares Held
104MCall Options Held
196KPut Options Held
199K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$208 Million64.24% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$68.7 Million0.0% of portfolio
-
Trigran Investments, Inc.7.7MShares$56.8 Million10.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.8MShares$50.2 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.65MShares$27 Million3.06% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $838M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...